title: Clinical usefulness of terbutaline in the management of placenta praevia.
abstract: Terbutaline was given to five patients with complete placenta praevia in order to prevent massive bleeding while at the same time prolonging the pregnancy. The longest period gained on therapy was 48 days and the shortest was 6 days. Doses of terbutaline used in these periods were 0.71-4.47 mg/dl. No serious complications were observed.
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D010923:Placenta Previa / Q000150:complications*; D011247:Pregnancy; D011255:Pregnancy Maintenance / Q000187:drug effects*; D013726:Terbutaline / Q000627:therapeutic use*; D014590:Uterine Contraction / Q000187:drug effects*; D014592:Uterine Hemorrhage / Q000209:etiology
chemical_list: D013726:Terbutaline